Council

Professor Sun-Wei Guo

President:
Professor Sun-Wei Guo, M.Med., M.Sc., Ph.D.
(Shanghai Obstetrics and Gynecology Hospital Fudan University Shanghai China)
President’s message

Endometriosis and adenomyosis are gynecological diseases characterized by the deposition and growth of endometrial lining. The two diseases are closely related and are both fairly prevalent, with 10% prevalence for endometriosis and as high as 30-40% in older women for adenomyosis. Both can lead to debilitating pelvic pain, menstrual pain, excessive menstrual bleeding and reduced fertility. Although benign, their treatment can be quite challenging due to our limited knowledge about their causes and pathophysiology, and both require long-term treatment throughout a woman’s reproductive years. While neither can be fatal, they can both cause havoc to afflicted women, racking their career, quality of life and family relationship. Extensive research in the last decade has shown that the treatment of endometriosis and/or adenomyosis can be very expensive. In short, endometriosis and adenomyosis are now a major health concern for reproductive women, and exert a heavy social and economical burden to afflicted women, their families and the society as a whole.

As the world’s largest and the most populous continent, Asia hosts 60% of the entire world’s population and, presumably, has more women of reproductive age than all the rest continents combined. Without any data to show that Asian women are any different from those in the other continents, the prevalence of endometriosis and adenomyosis can be assumed to be pretty high. In other words, it is highly likely that Asia has more women with endometriosis/adenomyosis than all the remaining continents combined.

Unfortunately, there is a lack of adequate awareness of endometriosis/adenomyosis in Asia in general. As a result, women and adolescent girls with either of the conditions often do not get prompt diagnosis and adequate care, which aggregates their pain and suffering and exert heavier burden to them, their families and the society.

The Asian Society of Endometriosis and Adenomyosis (ASEA) is founded by scientists and clinicians in China, Japan, Korea, Taiwan, and Turkey in 2010 and now has member countries that include Iran, Jordan, Philippine, Sri Lanka, Thailand, and Russia. Its mission is to raise awareness of the two diseases, to advance our knowledge about them, and to facilitate the dissemination of innovations and better clinical care for the two diseases, with the ultimate goal to improve the lives of all afflicted women and their loved ones. The ASEA tries to accomplish its mission through its annual Asian Conference on Endometriosis (ACE) and collaboration with all stakeholders and global partners.
As the current President of ASEA, I invite all like-minded scientists and clinicians to come on board and join me in this exciting journey to find better diagnostic and prognostic procedures, better treatment and, even better, the most effective prevention measures and cure.

The World Endometriosis Society (WES) advances evidence-based standards and innovations for education, advocacy, clinical care, and research in endometriosis and related disorders, in collaboration with its stakeholders and global partners to improve the lives of all afflicted women and their families.

Professor Tasuku Harada

Past President:
Professor Tasuku Harada
(Tottori University, Japan)

Professor Yong Taik Lim

Past President:
Professor Yong Taik Lim
(The Catholic University of Korea)